Discovery of a novel histone deacetylase 8 inhibitor by virtual screening

被引：18

作者：

Zhang, Lei ^{[1
]}

Li, Minyong ^{[1
]}

Feng, Jinhong ^{[1
]}

Fang, Hao ^{[1
]}

Xu, Wenfang ^{[1
]}

机构：

[1] Shandong Univ, Dept Med Chem, Sch Pharm, Jinan 250012, Shandong, Peoples R China

来源：

MEDICINAL CHEMISTRY RESEARCH | 2012年 / 21卷 / 02期

基金：

国家高技术研究发展计划(863计划);

关键词：

Histone deacetylase inhibitors; Virtual screening; Pharmacophore modeling; Docking; INCREMENTAL CONSTRUCTION; HDAC INHIBITORS; ACETYLATION; FAMILY; CANCER; UBIQUITINATION;

D O I：

10.1007/s00044-010-9519-7

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

In order to develop potent histone deacetylase inhibitors, a virtual screening approach was performed to discover novel lead structures. A commercial database containing about 167,000 molecules was in silico filtered by rule of five, zinc-binding groups, pharmacophore models, and binding pattern analysis. At last, three molecules were selected for enzyme inhibition assay, and one compound 02 has IC(50) of 1.6 mu M against histone deacetylase 8 (HDAC8).

引用

页码：152 / 156

页数：5

共 50 条

[1] Discovery of a novel histone deacetylase 8 inhibitor by virtual screening
Lei Zhang
Minyong Li
Jinhong Feng
Hao Fang
Wenfang Xu
Medicinal Chemistry Research, 2012, 21 : 152 - 156
[2] An Improved Protocol for the Virtual Screening Discovery of Novel Histone Deacetylase Inhibitors
Song, Qiuhang
Liu, Tingting
Liu, Yucui
Wang, Shuyue
Fan, Cong
Zheng, Lihua
Bao, Yongli
Sun, Luguo
Yu, Chunlei
Sun, Ying
Song, Zhenbo
Wang, Guannan
Huang, Yanxin
Li, Yuxin
CHEMICAL & PHARMACEUTICAL BULLETIN, 2019, 67 (10) : 1076 - 1081
[3] Virtual screening and experimental validation of novel histone deacetylase inhibitors
Yan-xin Huang
Jian Zhao
Qiu-hang Song
Li-hua Zheng
Cong Fan
Ting-ting Liu
Yong-li Bao
Lu-guo Sun
Li-biao Zhang
Yu-xin Li
BMC Pharmacology and Toxicology, 17
[4] Virtual screening and experimental validation of novel histone deacetylase inhibitors
Huang, Yan-xin
Zhao, Jian
Song, Qiu-hang
Zheng, Li-hua
Fan, Cong
Liu, Ting-ting
Bao, Yong-li
Sun, Lu-guo
Zhang, Li-biao
Li, Yu-xin
BMC PHARMACOLOGY & TOXICOLOGY, 2016, 17
[5] Ligand and structure based pharmacophore modeling to facilitate novel histone deacetylase 8 inhibitor design
Thangapandian, Sundarapandian
John, Shalini
Sakkiah, Sugunadevi
Lee, Keun Woo
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (10) : 4409 - 4417
[6] Virtual screening for early identification of potent and selective histone deacetylase 6 inhibitor series
Stachel, Shawn J.
Wang, Deping
Ginnetti, Anthony T.
Niroomand, Shahriar
Ma, Lei
Hu, Yinghui
Fay, John F.
Lemaire, Wei
Krosky, Daniel J.
Ramirez, Andres D.
Zariwala, Hatim A.
Coleman, Paul J.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2023, 96
[7] Emerging approaches for histone deacetylase inhibitor drug discovery
Zwergel, Clemens
Valente, Sergio
Jacob, Claus
Mai, Antonello
EXPERT OPINION ON DRUG DISCOVERY, 2015, 10 (06) : 599 - 613
[8] Construction of a Novel Scoring Function by Using a Genetic Algorithm for Virtual Screening of Histone Deacetylase Inhibitors (HDACi)
Xiang, Yuhong
Wei, Yanbo
Zhang, Zhuoyong
Hou, Zhaoyan
2013 NINTH INTERNATIONAL CONFERENCE ON NATURAL COMPUTATION (ICNC), 2013, : 428 - 433
[9] Discovery of Potent and Isoform-selective Histone Deacetylase Inhibitors Using Structure-based Virtual Screening and Biological Evaluation
Peng, Zhe
Zhao, Quanfeng
Tian, Xiaoyan
Lei, Tiantian
Xiang, Rongfeng
Chen, Lin
Yang, Yang
MOLECULAR INFORMATICS, 2022, 41 (09)
[10] A Novel Class of Schistosoma mansoni Histone Deacetylase 8 (HDAC8) Inhibitors Identified by Structure-Based Virtual Screening and In Vitro Testing
Simoben, Conrad V.
Robaa, Dina
Chakrabarti, Alokta
Schmidtkunz, Karin
Marek, Martin
Lancelot, Julien
Kannan, Srinivasaraghavan
Melesina, Jelena
Shaik, Tajith B.
Pierce, Raymond J.
Romier, Christophe
Jung, Manfred
Sippl, Wolfgang
MOLECULES, 2018, 23 (03):

← 1 2 3 4 5 →